Global Addictions Therapeutics Market Size, Status and Forecast 2020-2026
Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.
With the rising alcohol, opioid, and tobacco addiction across the world, many public, private, and government organizations are conducting programs to increase awareness about substance abuse and its health implications. For instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) in the US sponsors the Recovery Month to increase awareness about mental and substance use disorders and celebrate recovery. The organization also offers services to people with substance use disorders. Also, in countries such as India, government bodies provide financial assistance to many NGOs and urban local agencies to carry out combines services to spread awareness and rehabilitate individuals with addiction disorders.
Market Analysis and Insights: Global Addictions Therapeutics Market
In 2019, the global Addictions Therapeutics market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Addictions Therapeutics Scope and Market Size
Addictions Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Addictions Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Addictions Therapeutics market is segmented into Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, Drug Addiction Therapeutics, etc.
Segment by Application, the Addictions Therapeutics market is segmented into Public, Private, Government, etc.
Regional and Country-level Analysis
The Addictions Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Addictions Therapeutics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Addictions Therapeutics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Addictions Therapeutics business, the date to enter into the Addictions Therapeutics market, Addictions Therapeutics product introduction, recent developments, etc.
The major vendors include Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Opiant Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., etc.
This report focuses on the global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Public
Private
Government
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Addictions Therapeutics are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
With the rising alcohol, opioid, and tobacco addiction across the world, many public, private, and government organizations are conducting programs to increase awareness about substance abuse and its health implications. For instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) in the US sponsors the Recovery Month to increase awareness about mental and substance use disorders and celebrate recovery. The organization also offers services to people with substance use disorders. Also, in countries such as India, government bodies provide financial assistance to many NGOs and urban local agencies to carry out combines services to spread awareness and rehabilitate individuals with addiction disorders.
Market Analysis and Insights: Global Addictions Therapeutics Market
In 2019, the global Addictions Therapeutics market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Addictions Therapeutics Scope and Market Size
Addictions Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Addictions Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Addictions Therapeutics market is segmented into Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics, Drug Addiction Therapeutics, etc.
Segment by Application, the Addictions Therapeutics market is segmented into Public, Private, Government, etc.
Regional and Country-level Analysis
The Addictions Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Addictions Therapeutics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Addictions Therapeutics Market Share AnalysisAddictions Therapeutics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Addictions Therapeutics business, the date to enter into the Addictions Therapeutics market, Addictions Therapeutics product introduction, recent developments, etc.
The major vendors include Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Opiant Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., etc.
This report focuses on the global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Market segment by Type, the product can be split into
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Market segment by Application, split into
Public
Private
Government
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Addictions Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Addictions Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Addictions Therapeutics are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
